Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
Less than a month after the FDA rejected MDMA for PTSD treatment, and days after the agency set a September meeting to discuss psychedelic and other treatments for PTSD, the Multidisciplinary Association for Psychedelic Studies (MAPS) awarded a $200,000 grant to Emory University researchers for a pilot study that could redefine treatment for Post-Traumatic Stress Disorder (PTSD). As the company stated, the study, led by Dr. Barbara Rothbaum and Dr. Jessica Maples-Keller at the Emory Healthcare Veterans Program in Atlanta, aims to explore the synergy between MDMA-assisted therapy and Massed Exposure Therapy (MPE) in treating PTSD.
Pioneering PTSD Therapies
Dr. Rothbaum, a pioneer …